Canadian Diabetes
Published quarterly, Canadian Diabetes provides practical, current information to family physicians on diagnosis and treatment issues associated with diabetes.
HYPOGLYCEMIA:UNDERSTANDING THE ENEMY
Since the publication of the Diabetes Control and Complications Trial (DCCT) (1) in patients with type 1 diabetes, and the United Kingdom Diabetes Prospective Study (UKPDS) (2) in patients with type 2 diabetes, intensive diabetes management (IDM) is considered the standard of care for patients with diabetes.
Ellen L. Toth MD FRCPC, Danièle Pacaud MD FRCPC
L’HYPOGLYCÉMIE : POUR MIEUX CONNAÎTRE L’ENNEMI
Depuis la publication des résultats de l’étude DCCT (1) (Diabetes Control and Complications Trial), menée auprès de patients atteints de diabète de type 1, et de l’étude UKPDS2 (United Kingdom Prospective Diabetes Study), faite auprès de patients atteints de diabète de type 2, le traitement intensif du diabète est maintenant considéré la norme chez les patients atteints de diabète.
Ellen L. Toth MD FRCPC, Danièle Pacaud MD FRCPC
CANADIAN DIABETES ASSOCIATION GUIDELINES FOR THE MANAGEMENT OF HYPOGLYCEMIA: HIGHLIGHTS
Clinical hypoglycemia is defined as a state in which a patient with diabetes has a low plasma glucose (PG) level, experiences autonomic symptoms (trembling, palpitations, sweating, anxiety) and/or neuroglycopenic symptoms (difficulty concentrating, confusion, weakness, dizziness, fatigue), and attains relief with the administration of a carbohydrate.
Jean-François Yale MD CSPQ, Danièle Pacaud MD FRCPC
Production of materials has been made possible through a financial contribution from the Public Health Agency of Canada.
© 2012 Copyright Canadian Diabetes Association